Researchers have developed a new robotic system that can carry out clinical breast examinations. The solution is expected to detect breast cancer early on and could transform the way in which women monitor their breast health.

Baylor researchers have made a significant discovery about the gut microbiome's influence on the body, focusing on the bacteria L. reuteri. This bacteria has been found to impact multiple organs, including reducing gut inflammation, suppressing bone loss, promoting wound healing, and improving social behavior in autism spectrum disorders.

Researchers are working to develop a small, implantable device which has the potential to sense and even treat cancer. This project has received a funding of 45 million dollars from the Advanced Research Projects Agency for Health.

Scientists have found that ‘mechanoresilient’ cancer cells which are resilient to mechanical stress multiply rapidly, have the potential to form secondary tumors and are also drug resistant.

Researchers have introduced new soft, miniaturized wearable devices that can be used to capture body sounds. This innovation will help healthcare professionals to continuously monitor the health of their patients.

With an aim to support complex biologic therapies, Thermo Fisher Scientific has successfully expanded its manufacturing capacity in St. Louis, USA. With this move, the firm has added manufacturing suites that will contain up to four Thermo Scientific Dynadrive Single-Use Bioreactors each capable of processing up to 5,000 liters.

Researchers have revealed new and crucial insights into enhancing treatment and diagnosis of multiple myeloma which is a cancer of the plasma cells.

A new study has revealed that the lifespans of bats could be reduced as their molecular mechanism which is thought to give bat species their long lives had been altered due to changes in the weather.

In a research study presented at the ESC Congress 2023, it was revealed that twelve months of anticoagulation could help improve the outcomes in cancer patients with minor blood clots.

Researchers have developed a new model that has the potential to predict the likeliness of a women developing and then dying from breast cancer within 10 years.